e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Diagnosis and management of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide in diagnosis and management of respiratory diseases
E. Dilka, A. Cuko, D. Argjiri, R. Kore, J. Beli, E. Shehu, E. Tashi, E. Ndreu, E. Nushi, A. Tanku, A. Simaku, P. Kapisyzi (Tirana, Albania)
Source:
Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session:
Diagnosis and management of respiratory diseases
Session type:
Thematic Poster Session
Number:
4159
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Dilka, A. Cuko, D. Argjiri, R. Kore, J. Beli, E. Shehu, E. Tashi, E. Ndreu, E. Nushi, A. Tanku, A. Simaku, P. Kapisyzi (Tirana, Albania). Exhaled nitric oxide in diagnosis and management of respiratory diseases. Eur Respir J 2013; 42: Suppl. 57, 4159
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Characterization of airway inflammation in patients with asthma COPD overlap syndrome using FeNO levels
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
The role of FeNO measurement in exploration of respiratory symptoms in children with no diagnosis of asthma
Source: International Congress 2015 – Paediatric epidemiology: pulmonary complications, bronchiolitis and asthma
Year: 2015
Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Temporal stability of feno measurement in COPD
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Exhaled nitric oxide in childhood asthma
Source: Annual Congress 2006 - Paediatric Respiratory Research Award
Year: 2006
Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
Source: Eur Respir J 2010; 35: 72-78
Year: 2010
Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008
Further evidence that FeNO directed therapy reduces asthma exacerbations
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Exhaled nitric oxide and the therapeutic regimens in childhood asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013
Small airway dysfunction and its role in pediatric asthma control assessment
Source: International Congress 2016 – Techniques and tools in paediatric asthma
Year: 2016
Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma
Source: Eur Respir J 2006; 27: 951-956
Year: 2006
Exhaled NO (FENO50) in COPD - Results from the TIE-study
Source: International Congress 2016 – Inflammatory biomarkers in airway diseases
Year: 2016
Exhaled nitric oxide as the sole determinant of therapy in all obstructive patients in a primary care setting: long-lasting effects on health related quality of life
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept